Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-10-27

FDA Approved: SIROLIMUS — Original Application (Dr. Reddy's Laboratories Limited)

View source ↗

Summary

FDA approved Dr. Reddy's Laboratories' original application for a generic sirolimus product, enabling its use as an immunosuppressant for transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sirolimus (Sirolimus)

Snippet

ORIG AP for SIROLIMUS (SIROLIMUS)